Biodegradable polymer sirolimus-eluting or durable polymer zotarolimus-eluting stents in high bleeding-risk patients with acute coronary syndrome: the BIOFLOW-DAPT randomized trial

European Heart Journal: Acute Cardiovascular Care · Published 2026-08-04 · DOI 10.1093/ehjacc/zuag089

Authors (24)

Nader Mankerious, Rayyan Hemetsberger, Adrian Wlodarczak, Béla Merkely, Henning Kelbæk, Guillaume Cayla, Jacek Legutko, Stefano Galli, Matthieu Godin, Gabor G Toth, Thibault Lhermusier, Mohammed Saad, Benjamin Honton, Francesca Sanguineti, Peter Laurenz Dietrich, Derk Frank, Francis Stammen, Bert Ferdinande, Johanne Silvain, Davide Capodanno, Holger Nef, Gert Richardt, Ralph Toelg, Marco Valgimigli

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Mankerious, N., Hemetsberger, R., Wlodarczak, A., et al. (2026). Biodegradable polymer sirolimus-eluting or durable polymer zotarolimus-eluting stents in high bleeding-risk patients with acute coronary syndrome: the BIOFLOW-DAPT randomized trial. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuag089

Related articles